N Shoji - Expert Review of Ophthalmology, 2007 - ingentaconnect.com Brinzolamide is indicated for the reduction of intraocular pressure (IOP) in
eyes with ocular hypertension or open-angle glaucoma. Brinzolamide is an
effective inhibitor of carbonic anhydrase and lowers IOP by suppressing ... Cited by 2 - Related articles - BL Direct - All 3 versions
M Iester - Expert Opin. Pharmacother., 2008 - informahealthcare.com Primary open-angle glaucoma is a multifactorial optic neuropathy characterized
by the progressive loss of retinal ganglion cells and their axons. However, the
primary risk factor is elevated intraocular pressure (IOP), which can ... Cited by 2 - Related articles - BL Direct - All 6 versions
M Iester, 2008 - pubmedcentral.nih.gov Brinzolamide is a white powder commercially formulated as a 1% ophthalmic
suspension to reduce intraocular pressure (IOP). Pharmacologically, brinzolamide
is a highly specific, non-competitive, reversible, and effective inhibitor ... Related articles - All 6 versions
DA Sica - Side effects of drugs annual 29: a worldwide yearly …, 2007 - books.google.com Domenic A. Sica 21 Diuretics ГЧ. Hyponatremia and loop and thiazide diuretics
DoTS classification: Reaction: Hyponatremia and loop and thiazide diuretics
Dose-relation: Collateral Time-course: Time independent, but typically ... Related articles - All 2 versions
T CUMURCU - firattipdergisi.com Primer açık açılı glokom (PAAG) tanısı ile takip edilen yaşlı bir
hastada topikal karbonik anhidraz inhibitörü kullanımı sonrası gelişen
geri dönüşümsüz bir kornea ödemi olgusunu değerlendirmek. 81 ... Related articles - Cached - All 2 versions
O Sunumu - firattipdergisi.com Gaziosmanpaşa Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim
Dalı, TOKAT ÖZET Primer açık açılı glokom (PAAG) tanısı ile takip
edilen yaşlı bir hastada topikal karbonik anhidraz inhibitörü ... Related articles - View as HTML - All 3 versions